The levels of RANTES (CCl5) were significantly decreased in sarcoidosis patients compared to HP (p = 0.0003), amiodarone lung (p = 0.001), and EGPA (p = 0.005) patients. This evidence concerns the gene CCL5 and sarcoidosis.